Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harsh Bansia

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Chemical Society|July 25, 2022
Discovery of a Transferrin Receptor 1-Binding Aptamer and Its Application in Cancer Cell Depletion for Adoptive T-Cell Therapy ManufacturingEmmeline L Cheng, Ian I Cardle, Nataly Kacherovsky, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Beta-arrestin 1 mediated Src activation via Src SH3 domain revealed by cryo-electron microscopyNatalia Pakharukova, Brittany N Thomas, Harsh Bansia, et al.
Nature Communications|February 20, 2026
Mechanism of beta-arrestin 1 mediated Src activation via Src SH3 domain revealed by cryo-electron microscopyNatalia Pakharukova, Brittany N Thomas, Harsh Bansia, et al.
The Journal of Clinical Investigation|November 26, 2024
Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain modelsChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2026
Sym024 interacts with a unique epitope on the CD73 homodimer, favoring effective bivalent binding to improve anti-PD1 therapyJanus S Jakobsen, Michael M Grandal, Randi W Hansen, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Neuropilin-1 is a co-receptor for Nerve Growth Factor-evoked painChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Plos One|September 20, 2023
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell clusterStine Sofie Frank Lende, Nanna Møller Barnkob, Randi Westh Hansen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Chemical Society|July 25, 2022
Discovery of a Transferrin Receptor 1-Binding Aptamer and Its Application in Cancer Cell Depletion for Adoptive T-Cell Therapy ManufacturingEmmeline L Cheng, Ian I Cardle, Nataly Kacherovsky, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Beta-arrestin 1 mediated Src activation via Src SH3 domain revealed by cryo-electron microscopyNatalia Pakharukova, Brittany N Thomas, Harsh Bansia, et al.
Nature Communications|February 20, 2026
Mechanism of beta-arrestin 1 mediated Src activation via Src SH3 domain revealed by cryo-electron microscopyNatalia Pakharukova, Brittany N Thomas, Harsh Bansia, et al.
The Journal of Clinical Investigation|November 26, 2024
Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain modelsChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2026
Sym024 interacts with a unique epitope on the CD73 homodimer, favoring effective bivalent binding to improve anti-PD1 therapyJanus S Jakobsen, Michael M Grandal, Randi W Hansen, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Neuropilin-1 is a co-receptor for Nerve Growth Factor-evoked painChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Plos One|September 20, 2023
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell clusterStine Sofie Frank Lende, Nanna Møller Barnkob, Randi Westh Hansen, et al.
Pageof 2